New hope for elderly lymphoma patients: antibody therapy without harsh chemo
NCT ID NCT05660967
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study tests a drug called epcoritamab, given alone or with another drug (lenalidomide), in elderly patients with a type of lymphoma (DLBCL) who cannot receive standard chemotherapy. The goal is to see how well the treatment shrinks tumors and how safe it is. All 111 participants will receive active treatment, and they have an equal chance of getting epcoritamab alone or the combination.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AUSL Piacenza Ospedale Guglielmo da Saliceto
Piacenza, Italy
-
AZ Delta
Roeselare, Belgium
-
AZ Turnhout - Campus Sint-Elisabeth
Turnhout, Belgium
-
Asan Medical Center
Seoul, South Korea
-
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS
Bologna, Italy
-
Azienda Ospedaliera Vincenzo Cervello
Palermo, Italy
-
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)
Brescia, Italy
-
Azienda sanitaria integrata università di Trieste
Trieste, Italy
-
CHU Amiens - Hopital Sud
Salouël, France
-
CHU Angers - Hôpital Hôtel Dieu
Angers, France
-
CHU Tours - Hôpital Bretonneau
Tours, France
-
CHU de Bordeaux - Hôpital Haut-Lévêque
Pessac, France
-
CHU de Nantes - Hotel Dieu
Nantes, France
-
Cancer Institute Hospital of JFCR
Kōtoku, Japan
-
Centrum Medyczne Pratia Poznan
Skorzewo, Poland
-
Clinica di Ematologia AOU Ospedali Riuniti di Ancona
Ancona, Ancona, Italy
-
Derriford Hospital
Plymouth, United Kingdom
-
Fakultni nemocnice Hradec Kralove
Hradec Králové, Czechia
-
Fakultni nemocnice v Motole
Prague, Czechia
-
Fondazione del Piemonte per l'Oncologia IRCC Candiolo
Candiolo, Italy
-
Hopital Claude Huriez - CHRU Lille
Lille, France
-
Hopital de la Conception - APHM
Marseille, France
-
Hospital Clinic de Barcelona
Barcelona, Spain
-
Hospital General Universitario Gregorio Marañon
Madrid, Spain
-
Hospital San Pedro de Alcantara
Cáceres, Spain
-
Hospital Universitario 12 de Octubre
Madrid, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain
-
Hospital Universitario Nuestra Señora de Valme
Seville, Spain
-
Hospital Universitario Puerta del Mar
Seville, Spain
-
Hospital Universitario Ramon y Cajal
Madrid, Spain
-
Hospital Universitario Virgen Macarena
Seville, Spain
-
Hôpital Henri Mondor
Créteil, France
-
Hôpital Saint-Antoine
Paris, France
-
Hôpital Saint-Louis
Paris, France
-
ICO Badalona - Hospital Universitari Germans Trias i Pujol
Badalona, Spain
-
ICO l'Hospitalet - Hospital Duran i Reynals
Barcelona, Spain
-
IEO Istituto Europeo di Oncologia Parent
Milan, Italy
-
IRCCS Centro di Riferimento Oncologico
Aviano, Italy
-
IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" - IRST
Meldola, Italy
-
Institut Jules Bordet
Anderlecht, Belgium
-
Jeonbuk National University Hospital
Jeonju, South Korea
-
Kagoshima University Hospital
Kagoshima, Japan
-
Kanazawa University Hospital
Kanazawa, Japan
-
Keimyung University Dongsan Hospital
Daegu, South Korea
-
Kepler Universitätsklinikum
Linz, Austria
-
Kindai University Hospital
Ōsaka-sayama, Japan
-
Klinikum Wels-Grieskirchen GmbH
Wels, Austria
-
Kyushu University Hospital
Fukuoka, Japan
-
LKH - Universitätsklinikum der PMU Salzburg
Salzburg, Austria
-
MICS Centrum Medyczne Torun
Torun, Poland
-
Matsuyama Red Cross Hospital
Matsuyama, Japan
-
NHO Nagoya Medical Center
Nagoya, Japan
-
National Cancer Center
Goyang-si, South Korea
-
National Cancer Center Hospital East
Kashiwa, Japan
-
Ospedale San Raffaele
Milan, Italy
-
Pratia MCM Krakow
Krakow, Poland
-
Royal Cornwall Hospital NHS Trust
Truro, United Kingdom
-
Royal Marsden Hospital
Sutton, United Kingdom
-
Royal Marsden Hospital - Fulham
London, United Kingdom
-
Samsung Medical Center
Seoul, South Korea
-
Seoul National University Hospital
Seoul, South Korea
-
Southampton General Hospital
Southampton, United Kingdom
-
UW Cancer Center at ProHealth Care
Waukesha, Wisconsin, 53188, United States
-
UZ Brussels
Jette, Belgium
-
UZ Leuven
Leuven, Belgium
-
Universitaetsklinikum Aachen AOeR
Aachen, Germany
-
Universitaetsklinikum Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany
-
Universitaetsklinikum Wuerzburg
Würzburg, Germany
-
Vitaz
Temse, Belgium
-
Vivantes Klinikum Neukoelln
Berlin, State of Berlin, Germany
-
Vseobecna fakultni nemocnice v Praze
Prague, Czechia
-
Wojewodzki Szpital Specjalistyczny w Bialej Podlaskiej
Biała Podlaska, Poland
-
Yamagata University Hospital
Yamagata, Japan
-
ZNA
Antwerp, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can an immune booster outsmart brain lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can donor immune cells be engineered to fight blood cancer?
- Can a simple blood test spot lymphoma earlier?
- Can a Light-Based device spot dangerous infection risk without a blood draw?